Jump to content

Draft:Shinji Fukuda

From Wikipedia, the free encyclopedia
  • Comment: Please read carefully the requirements for academics. While this article may describe him it does not demonstrate notability. Since someone else with the same name shows up in Google scholar, the notability of his publications is very unclear. Ldm1954 (talk) 21:45, 13 September 2024 (UTC)

Shinji Fukuda

[edit]

Shinji Fukuda (福田真嗣, Fukuda Shinji) is the Project Professor at the Institute for Advanced Biosciences, Keio University, in Tokyo, Japan. He is a leading researcher in the field of gut microbiome analysis and evaluation. Known for his efforts to raise awareness about the importance of gut health, he often refers to feces as "brown diamonds.".[1]

Background

[edit]

From a young age, Fukuda was fascinated by microorganisms. This interest was solidified when he received a microscope for his 10th birthday, which set him on the path to a career in science[2]. He became interested in the world of intestinal environment research at the university where he entered to study biotechnology.

Fukuda completed his Doctoral Program in Agricultural Science at Meiji University Graduate School in 2006, and subsequently obtained a Ph.D. in Gut Microbiology. He then joined RIKEN as a Special Researcher. In 2012, he became a Project Associate Professor at the Institute for Advanced Biosciences, Keio University, and was later promoted to Project Professor[3]. Additionally, in 2015, he became a researcher at the Japan Science and Technology Agency[4] and has been serving as the President and CEO of Metagen Inc.[5] concurrently since the same year. He also holds positions as a Visiting Professor at the University of Tsukuba's Faculty of Medicine[6], Group Leader at the Kanagawa Prefectural Institute of Industrial Science and Technology, and Visiting Professor at the Malaysia-Japan International Institute of Technology, Malaysia University of Technology. Furthermore, he is the founder of and Senior Scientific Advisor to Metagen Therapeutics Inc., Director of Metagen Singapore Pte. Ltd., the Representative Director of the Japan Gut Design Association[7], and Specially Appointed Professor at the Department of Bacteriology, Graduate School of Medicine, Juntendo University[8]

He is active in the media to implement his research and ideas on a social scale.

Awards and Honors

[edit]
  • 2013: Young Scientists' Prize from the Ministry of Education, Culture, Sports, Science and Technology (MEXT)[9]
  • 2014: Mishima Kaiun Academic Award[10]
  • 2014: Yamagata Prefecture Science and Technology Encouragement Award.[11]
  • 2015: Selected for MEXT's "Contributions to Science and Technology 2015"
  • 2015: Bioscience Grand Prize for Best Business Plan for "Creating a Healthy Society from Feces"[12]
  • 2016: Ando Momofuku Award for Invention and Discovery Encouragement[13]
  • 2017: Bioindustry Encouragement Award[14]

Selected Works

[edit]

1. Mizutani S, Tamaki A, Shiba S, Salim F, Yamada M, Takamaru H, Nakajima T, Yoshida N, Ikuta S, Yachida T, Shibata T, Soga T, Saito Y, Fukuda S, Ishikawa H, Yamada T, Yachida S. Dynamics of the gut microbiome in FAP patients undergoing intensive endoscopic reduction of polyp burden. Gut 2024. https://gut.bmj.com/content/early/2024/08/01/gutjnl-2024-332381

2. Steimle A, Neumann M, Grant ET, Willieme S, De Sciscio A, Parrish A, Ollert M, Miyauchi E, Soga T, Fukuda S, Ohno H, Desai MS. Gut microbial factors predict disease severity in a mouse model of multiple sclerosis. Nat. Microbiol. 2024. https://www.nature.com/articles/s41564-024-01761-3

3. Kawamoto S, Uemura K, Hori N, Takayasu L, Konishi Y, Katoh K, Matsumoto T, Suzuki M, Sakai Y, Matsudaira T, Adachi T, Ohtani N, Standley DM, Suda W, Fukuda S, Hara E. Bacterial induction of B cell senescence promotes age-related changes in the gut microbiota. Nat. Cell Biol. 25: 865, 2023. https://europepmc.org/article/med/37169880

4. Zhu X, Sakamoto S, Ishii C, Smith MD, Ito K, Obayashi M, Unger L, Hasegawa Y, Kurokawa S, Kishimoto T, Li H, Hatano S, Wang TH, Yoshikai Y, Kano SI, Fukuda S, Sanada K, Calabresi PA, Kamiya A. Dectin-1 signaling on colonic γδ T cells promotes psychosocial stress responses. Nat. Immunol. 24: 625, 2023. https://www.nature.com/articles/s41590-023-01447-8

5. Nagai M, Moriyama M, Ishii C, Mori H, Watanabe H, Nakahara T, Yamada T, Ishikawa D, Ishikawa T, Hirayama A, Kimura I, Nagahara A, Naito T*, Fukuda S*, Ichinohe T*. High body temperature increases gut microbiota-dependent host resistance to influenza A virus and SARS-CoV-2 infection. Nat. Commun. 14: 3863, 2023. https://www.nature.com/articles/s41467-023-39569-0

6. Morita H, Kano C, Ishii C, Kagata N, Ishikawa T, Hirayama A, Uchiyama Y, Hara S, Nakamura T, Fukuda S*. Bacteroides uniformis and its preferred substrate, α-cyclodextrin, enhances endurance exercise performance in mice and human males. Sci. Adv. 2023; 9: eadd2120. https://www.science.org/doi/10.1126/sciadv.add2120

7. Yamagishi R, Kamachi F, Nakamura M, Yamazaki S, Kamiya T, Takasugi M, Cheng Y, Nonaka Y, Yukawa-Muto Y, Thuy LTT, Harada Y, Arai T, Loo TM, Yoshimoto S, Ando T, Nakajima M, Taguchi H, Ishikawa T, Akiba H, Miyake S, Kubo M, Iwakura Y, Fukuda S, Chen WY, Kawada N, Rudensky A, Nakae S, Hara E, Ohtani N. Gasdermin D-mediated release of IL-33 from senescent hepatic stellate cells promotes obesity-associated hepatocellular carcinoma. Sci. Immunol. 2022; 7: eabl7209. https://www.science.org/doi/10.1126/sciimmunol.abl7209

8. Nakamura A, Kurihara S, Takahashi D, Ohashi W, Nakamura Y, Kimura S, Onuki M, Kume A, Sasazawa Y, Furusawa Y, Obata Y, Fukuda S, Saiki S, Matsumoto M, Hase K. Symbiotic polyamine metabolism regulates epithelial proliferation and macrophage differentiation in the colon. Nat. Commun. 12: 2105, 2021. https://www.nature.com/articles/s41467-021-22212-1

9. Caballero-Flores G, Pickard JM, Fukuda S, Inohara N, Núñez G. An Enteric Pathogen Subverts Colonization Resistance by Evading Competition for Amino Acids in the Gut. Cell Host Microbe 2020; 28: 526-533. https://pubmed.ncbi.nlm.nih.gov/32726577/

10. Erawijantari PP, Mizutani S, Shiroma H, Shiba S, Nakajima T, Sakamoto T, Saito Y, Fukuda S, Yachida S, Yamada T. Influence of gastrectomy for gastric cancer treatment on faecal microbiome and metabolome profiles. Gut 2020; 69:1404-1415. https://gut.bmj.com/content/69/8/1404

  1. ^ "「便は茶色い宝石」 腸内環境デザインで健康寿命100歳を目指す | Forbes JAPAN 公式サイト（フォーブス ジャパン）".
  2. ^ "福田真嗣特任教授 - 研究者インタビュー - 研究ハイライト - 研究紹介 - 慶應義塾大学先端生命科学研究所".
  3. ^ "研究者詳細 - 福田 真嗣".
  4. ^ "[Shinji Fukuda] Development of fundamental technology for preventive and therapeutic medicine through intestinal metabolites-targeted approach | PRESTO".
  5. ^ "Metabologenomics, Inc. | Global Startup Acceleration Program (GSAP) Alumni - Acceleration Program Startup - Japan External Trade Organization". 2024.
  6. ^ "TMRC - Transborder Medical Research Center".
  7. ^ "腸内デザイン学会".
  8. ^ "順天堂大学とメタジェンセラピューティクスが共同研究講座「細菌叢再生学講座」を開設｜ニュース＆イベント｜順天堂大学".
  9. ^ https://www.mext.go.jp/b_menu/houdou/25/04/__icsFiles/afieldfile/2013/04/10/1332785_02_1.pdf
  10. ^ "三島海雲記念財団 | 自然科学部門 受賞者".
  11. ^ https://www.pref.yamagata.jp/documents/3356/r5itiran.pdf
  12. ^ "Dr.Shinji Fukuda wins the first prize of the 1st Biosciences Grand Prix - Research & educational activities of TTCK are mainly done in Institute for Advanced Biosciences".
  13. ^ "過去の受賞者".
  14. ^ https://www.jba.or.jp/web_file/award_release_shourei2017.pdf
Retrieved from "https://en.wikipedia.org/w/index.php?title=Draft:Shinji_Fukuda&oldid=1245588069"